Evidence map›Paper›PMID 37508210›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Differential Antimicrobial Effect of Three-Sized Biogenic Silver Nanoparticles as Broad-Spectrum Antibacterial Agents against Plant Pathogens.

Munirah F Aldayel, Nermin El Semary, David G Adams

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review of Antimicrobial Properties of Carbon Nanomaterials.International journal of molecular sciences · 2026
    Review
  5. Review
  6. Article
  7. Silver and Gold Compounds as Antibiotics.Antibiotics (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Munirah F AldayelBiological Sciences Department, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-2732-6230
Nermin El SemaryBiological Sciences Department, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-3179-0351
David G AdamsFaculty of Biological Sciences, Leeds University, Leeds LS2 9JT, UK.
King Faisal University · SAUniversity of Leeds · GB

Funding

King Faisal University 3141
6 · The paper itself

Abstract

backgroundMassive fruit losses are caused by microbial pathogens of unknown identities. Therefore, ecofriendly biocontrol measures are well sought after, and biogenic silver nanoparticles are plausible candidates. Here we investigate the antimicrobial effect of three different sized AgNPs samples on those pathogens. METHODOLOGY: Identities of three local pathogenic bacteria were investigated using molecular methods. Three different-sized samples of silver nanoparticles were bio-synthesized in the external solution of a cyanobacterial culture, characterized, and used in antimicrobial bioassay.

resultsThe pathogens were identified as DISCUSSION: The identity of the pathogens infecting different local fruits is reported for the first time. They belong to different bacterial lineages. The fact that biogenic AAgNPs were effective against all of them shows their broad-spectrum of antibacterial effect. Customized biosynthesis was successful in yielding different-sized AgNPs. The smaller the AgNPs, the stronger the antimicrobial impact.

conclusionLocal bacterial species infecting fruits are diverse. Customized biogenic AgNPs are effective broad-spectrum biocontrol agents against bacterial pathogens of local fruits and thereby help maintain food security and environmental sustainability.

Indexed as

antimicrobialcyanobacteriaenvironmental sustainabilityfruitsplant pathogenic bacteriasilver nanoparticles

Identifiers

PMID37508210
PMCPMC10376758
OpenAlexW4382726121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.